John Shaw
Director/Board Member at Biocon Sdn. Bhd.
Net worth: 849 M $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kiran Mazumdar-Shaw | F | 71 |
Biocon SA
 Biocon SA Pharmaceuticals: MajorHealth Technology Part of Biocon Ltd., Biocon SA develops and manufactures pharmaceuticals.
Glenloch Properties Pvt Ltd.
Mazumdar Shaw Medical Foundation
Biocon Foundation
Syngene Employee Welfare Trust
 Syngene Employee Welfare Trust Investment ManagersFinance Syngene Employee Welfare Trust operates as the employee welfare trust entity of Syngene International Ltd. The company is headquartered in India.
Biocon Biopharmaceuticals Pvt Ltd.
 Biocon Biopharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Biocon Ltd., Biocon Biopharmaceuticals Pvt Ltd. develops and manufactures pharmaceuticals. The private company is based in Bangalore, India.
Glentec International
Biocon Ltd. Employee Welfare Trust
Biocon Sdn. Bhd.
 Biocon Sdn. Bhd. Pharmaceuticals: MajorHealth Technology Biocon Sdn. Bhd. manufactures insulin products. It provides research and development activities of biopharmaceutical products. The company was founded in 2010 and is headquartered in Nusajaya, Malaysia.
Biocon Research Ltd.
 Biocon Research Ltd. Pharmaceuticals: MajorHealth Technology Part of Biocon Ltd., Biocon Research Ltd. is an Indian company that develops and sells biotechnology products. The private company is based in Bangalore, India. | - |
| Daniel Bradbury | M | 62 |
Biocon Biologics Uk Ltd.
 Biocon Biologics Uk Ltd. Miscellaneous Commercial ServicesCommercial Services Biocon Biologics UK Ltd. is a biopharmaceutical company founded in 2016. The private company is based in London, UK. The British company is focused on finding new and affordable ways to treat diabetes, cancer, and autoimmune diseases. Biocon develops affordable biosimilars, generic formulations, and complex APIs. The company's work in novel biologics and novel targets in large molecules has significant results in diabetes, oncology, and immunology. The company provides access to share information, news, press releases, company statements, media stories, factsheet, leadership profile, reports, video, and image gallery. Syngene, a division of Biocon, is divided into four divisions - drug discovery services, drug development services, manufacturing services, and dedicated R&D centers.
Biocon Research Ltd.
Biocon Research Ltd. Pharmaceuticals: MajorHealth Technology Part of Biocon Ltd., Biocon Research Ltd. is an Indian company that develops and sells biotechnology products. The private company is based in Bangalore, India. | 11 years |
| Arun Suresh Chandavarkar | M | 62 |
Biocon Biopharmaceuticals Pvt Ltd.
Biocon Biopharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Biocon Ltd., Biocon Biopharmaceuticals Pvt Ltd. develops and manufactures pharmaceuticals. The private company is based in Bangalore, India.
Biocon Sdn. Bhd.
Biocon Sdn. Bhd. Pharmaceuticals: MajorHealth Technology Biocon Sdn. Bhd. manufactures insulin products. It provides research and development activities of biopharmaceutical products. The company was founded in 2010 and is headquartered in Nusajaya, Malaysia.
Biocon Research Ltd.
Biocon Research Ltd. Pharmaceuticals: MajorHealth Technology Part of Biocon Ltd., Biocon Research Ltd. is an Indian company that develops and sells biotechnology products. The private company is based in Bangalore, India. | 30 years |
| John Russell Fotheringham Walls | M | 80 |
Biocon Biologics Uk Ltd.
Biocon Biologics Uk Ltd. Miscellaneous Commercial ServicesCommercial Services Biocon Biologics UK Ltd. is a biopharmaceutical company founded in 2016. The private company is based in London, UK. The British company is focused on finding new and affordable ways to treat diabetes, cancer, and autoimmune diseases. Biocon develops affordable biosimilars, generic formulations, and complex APIs. The company's work in novel biologics and novel targets in large molecules has significant results in diabetes, oncology, and immunology. The company provides access to share information, news, press releases, company statements, media stories, factsheet, leadership profile, reports, video, and image gallery. Syngene, a division of Biocon, is divided into four divisions - drug discovery services, drug development services, manufacturing services, and dedicated R&D centers.
Biocon Research Ltd.
Biocon Research Ltd. Pharmaceuticals: MajorHealth Technology Part of Biocon Ltd., Biocon Research Ltd. is an Indian company that develops and sells biotechnology products. The private company is based in Bangalore, India. | 9 years |
| Mayank Verma | M | - | 12 years | |
| Siddharth Mittal | M | 46 | 11 years | |
| Vijay Kumar Kuchroo | M | 68 | 9 years | |
| Priyadarshini I. Mahapatra | F | - | 5 years | |
| Paul Blackburn | M | 70 |
Biocon Biologics Uk Ltd.
Biocon Biologics Uk Ltd. Miscellaneous Commercial ServicesCommercial Services Biocon Biologics UK Ltd. is a biopharmaceutical company founded in 2016. The private company is based in London, UK. The British company is focused on finding new and affordable ways to treat diabetes, cancer, and autoimmune diseases. Biocon develops affordable biosimilars, generic formulations, and complex APIs. The company's work in novel biologics and novel targets in large molecules has significant results in diabetes, oncology, and immunology. The company provides access to share information, news, press releases, company statements, media stories, factsheet, leadership profile, reports, video, and image gallery. Syngene, a division of Biocon, is divided into four divisions - drug discovery services, drug development services, manufacturing services, and dedicated R&D centers. | 10 years |
| Ravi Rasendra Mazumdar | M | 69 |
Glentec International
Biocon Biologics Uk Ltd.
Biocon Biologics Uk Ltd. Miscellaneous Commercial ServicesCommercial Services Biocon Biologics UK Ltd. is a biopharmaceutical company founded in 2016. The private company is based in London, UK. The British company is focused on finding new and affordable ways to treat diabetes, cancer, and autoimmune diseases. Biocon develops affordable biosimilars, generic formulations, and complex APIs. The company's work in novel biologics and novel targets in large molecules has significant results in diabetes, oncology, and immunology. The company provides access to share information, news, press releases, company statements, media stories, factsheet, leadership profile, reports, video, and image gallery. Syngene, a division of Biocon, is divided into four divisions - drug discovery services, drug development services, manufacturing services, and dedicated R&D centers. | 24 years |
| Damodaran Meleveetil | M | 77 | 8 years | |
| Kush Parmar | M | 42 | 3 years | |
| Vinita Kundanlal Bali | F | 67 | 7 years | |
| Sharmila Abhay Karve | F | 59 | 5 years | |
| Bobby Kanubhai Parikh | M | 60 | 6 years | |
| Jonathan Hunt | M | 55 | 9 years | |
| Akhilesh Nand | M | - | 6 years | |
| Teo Jua Chi | M | - |
Biocon Sdn. Bhd.
Biocon Sdn. Bhd. Pharmaceuticals: MajorHealth Technology Biocon Sdn. Bhd. manufactures insulin products. It provides research and development activities of biopharmaceutical products. The company was founded in 2010 and is headquartered in Nusajaya, Malaysia. | - |
| Sibaji Biswas | M | - | 5 years | |
| Kunal Ashok Kashyap | M | 59 |
Mazumdar Shaw Medical Foundation
| - |
| Pang See Wee | M | - |
Biocon Sdn. Bhd.
Biocon Sdn. Bhd. Pharmaceuticals: MajorHealth Technology Biocon Sdn. Bhd. manufactures insulin products. It provides research and development activities of biopharmaceutical products. The company was founded in 2010 and is headquartered in Nusajaya, Malaysia. | - |
| Caroline Hempstead | F | - | 5 years | |
| Amitava Saha | M | 54 | 11 years | |
| Catherine Rosenberg | M | 63 | 24 years | |
| Devi Prasad Shetty | M | 71 |
Mazumdar Shaw Medical Foundation
| - |
| Krishnan G. | M | - | 4 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Bala S. Manian | M | 77 | 16 years | |
| Charles Cooney | M | 80 | 14 years | |
| Suresh Narasappa Talwar | M | 86 | 16 years | |
| Neville Bain | M | 83 | 12 years | |
| S. S. Satish Kumar | M | - | 1 years | |
| M. B. Chinappa | M | - | - | |
| Purushottam Singnurkar | M | - | - | |
| Carl Decicco | M | 62 | 4 years | |
| Peter Bains | M | 65 | 7 years | |
| Mary Harney | F | 71 | 10 years | |
| Rajiv Balakrishnan | M | - | - | |
| Jeremy Levin | M | 70 | 5 years | |
| K. N. Murali Krishnan | M | 68 | 33 years | |
| Sanjeev Sukumaran | M | - | - | |
| Vinita Shrivastava | F | - | 1 years | |
| May Ferries | F | - |
University of Glasgow
| 4 years |
| Dame Catherine Mcguire | F | 75 |
University of Glasgow
| 1 years |
| Sergio Getrajdman | M | - | - | |
| Manoj Nerurkar | M | - | 9 years | |
| Laroia Gaurav | M | - | 2 years | |
| Narendra Chirmule | M | - | - | |
| Avril Chisholm Millar | F | 72 |
University of Glasgow
| 4 years |
| Thomas Privette | M | - | - | |
| Sigrid Martina Koeth | F | - | - | |
| Chanderlekha Nayar | F | - | 4 years | |
| B. S. V. Prasad | M | - | - | |
| Preeti Kalra | F | - | 2 years | |
| Ravi Limaye | M | 60 | - | |
| Sandeep Nilkanth Athalye | M | - | - | |
| Sebi Chacko | M | 55 | - | |
| Harish Iyer | M | 55 | - | |
| John Coleman | M | 71 |
University of Glasgow
| 4 years |
| Brian O'Neill | M | - |
University of Glasgow
| 4 years |
| David C. U'Prichard | M | 75 |
University of Glasgow
| 4 years |
| Frederick Stanislaus Hallsworth | M | 71 |
University of Glasgow
| 4 years |
| James F. Winchester | M | - |
University of Glasgow
| 3 years |
| John R. Gibson | M | - |
University of Glasgow
| 3 years |
| Rachna Aggarwal Sirdeshmukh | F | - |
Madura Coats Pvt Ltd.
 Madura Coats Pvt Ltd. TextilesProcess Industries Part of Coats Group Plc, Madura Coats Pvt Ltd. is a textile manufacturing private company based in Bangalore, India. Coats Ltd. on December 30, 2002 for $17.80 million. Madura Coats was acquired by J.&P. | - |
| Richard C. Campbell | M | 77 |
University of Glasgow
| 4 years |
| James Gordon Stewart | M | - |
University of Glasgow
| 4 years |
| Colin R. Gardner | M | - |
University of Glasgow
| 3 years |
| Rakesh Bamzai | M | - | 19 years | |
| Anupam Jindal | M | 48 | 1 years | |
| Suresh Subramanian | M | - | 3 years | |
| Ravi C. Dasgupta | M | - | - | |
| Abhijit Barve | M | - | - | |
| Robert Montgomery | M | 72 |
University of Glasgow
| 4 years |
| S Vijaya Kumar | M | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| India | 59 | 79.73% |
| United Kingdom | 17 | 22.97% |
| Malaysia | 4 | 5.41% |
| Mauritius | 2 | 2.70% |
| Switzerland | 1 | 1.35% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John Shaw
- Personal Network